Duane Nash, Director at Akebia Therapeutics, Inc. (AKBA), sold 1,981 shares at $8.96 ($18K) on 2016-10-03, disclosed to the SEC on 2016-10-04.
Scheduled sale ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IMUX | BUY | 2021-08-11 | $10K | — | Filing → |
| IMUX | BUY | 2021-05-12 | $51K | — | Filing → |
| IMUX | SELL | 2019-12-04 | $31K | — | Filing → |